TMEM273
≈ 4 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Transmembrane protein 273 (TMEM273) aka C10orf128, is a protein which in humans is encoded by the TMEM273 gene. This protein is found within the topological domain as TMEM273 is a single-pass type I membrane protein. Although the function TMEM273 is relatively novel within the scientific community, existing research has shown that the protein may mediate histone trimethylation modifications, immunosuppression, and macrophage chemotaxis inhibition. TMEM273 expression is ubiquitous and is associated with various diseases and illnesses. Recent studies have revealed likely links to lung adenocarcinomas and acute myeloid leukemia
Transmembrane protein 273 (TMEM273) aka C10orf128, is a protein which in humans is encoded by the TMEM273 gene. This protein is found within the topological domain as TMEM273 is a single-pass type I membrane protein. Although the function TMEM273 is relatively novel within the scientific community, existing research has shown that the protein may mediate histone trimethylation modifications, immunosuppression, and macrophage chemotaxis inhibition. TMEM273 expression is ubiquitous and is associated with various diseases and illnesses. Recent studies have revealed likely links to lung adenocarcinomas and acute myeloid leukemia
Gene
This gene is located on chromosome 10, long arm, region 1, band 1, sub-band 23 (10q11.23), and oriented on the minus strand in Homo sapiens, and contains 7 exons. The gene spans 33,656 base pairs. A common alias of TMEM273 is C10orf128. The locus of TMEM273 is denoted by the red line in the figure below.
mRNA
TMEM273 gene encodes 7 transcript variants. Transcript variant 2 contains an alternate exon in the central coding region, which results in a frameshift, compared to variant 1. However, the encoded isoform 2 has a longer and more distinct C-terminus. Transcript variant 2 is 1601 nt long, contains 7 exons, and is considered the MANE Select (most representative) variant.
Protein
TMEM273 isoform 2 contains 129 amino acids and has an approximate molecular weight of 14 kDa with an isoelectric point of 9.5.
Evolutionary history and homology
The TMEM gene family is very large and consists of integral membrane proteins serving vastly different functions. In addition to their wide variety of functions, TMEM proteins are expressed in many different organ types, and their mediation in physiological processes makes them attractive proteins to study disease etiology. TMEM273 first appeared approximately 462 million years ago in Chondrichthyes (cartilaginous fish). NCBI pBLAST yielded 2 splice isoforms of TMEM273 in the sevengill sharpnose shark, one of the most distantly related orthologs.
Phylogeny
Divergence
TMEM273 exhibits a higher evolutionary rate than cytochrome c. This is consistent with patterns seen in other rapidly evolving proteins such as fibrinogen alpha.
Clinical significance
Investigation of p53 mutation-based prognostic risk signatures for acute myeloid leukemia (AML) found TMEM273 to be a potential prognostic biomarker for patients with AML. Although this data is not fully extrapolated, an additional study into FMS-like tyrosine kinase 3 (FLT3) found TMEM273 to be expressed in FLT3-mutated AML. FLT3 is essential to hematopoiesis, and mutations in this gene are commonly seen in AML. Therefore it is possible that TMEM273's link to AML is a result of its mediation of FLT3. In a study targeting Ebola-associated genes within the human genome, TMEM273 was found to be a signal peptide expressed in blood plasma, indicating that the protein may play a role in controlling protein secretion and trafficking. Another study investigating surrogate biomarkers for protective immunity against Chlamydia trachomatis revealed TMEM273 to be a prerequisite for interleukin-13 (IL-13) production by CD4 clones, suggesting the protein to be a T-Cell biomarker. Specifically, TMEM273 was prominent in the CD4 and CD8 signatures of the genital tract. The implication that TMEM273 is a T-Cell biomarker could potentially illuminate why the protein is, prevalent in many different types of malignant tissue. An investigation into the prognosis of patients with lung adenocarcinoma (LUAD) found that poor prognosis was consistently related to histone hypotrimethylation level, decreased secretion of chemokines, macrophage chemotaxis inhibition, and immunosuppression; A TMEM-based signature was found to be closely related to these prognoses. The TMEM signature includes TMEM273, TMEM125 and TMEM163. The involvement of these proteins in mediating histone trimethylation modifications, immunosuppression, and macrophage chemotaxis inhibition is likely the cause of this result.
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1375713311 under CC BY-SA 4.0; modifications have been made.